Alex M. Cranberg
Founder at Aspect Holdings LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeno Gyuris | M | 64 |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan.
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | - |
Robert Todd Neugebauer | M | - |
Aspect Energy LLC (Colorado)
Aspect Energy LLC (Colorado) Oil & Gas ProductionEnergy Minerals Aspect Energy LLC operates as an exploration and energy investment company. The firm is engaged in oil and gas exploration and development efforts. The company was founded in 1992 and is headquartered in Denver, CO.
Aspect Holdings LLC
Aspect Holdings LLC Financial ConglomeratesFinance Aspect Holdings LLC provides investments in oil and gas exploration companies. It engages in exploration and production activities in a number of countries, including the United States, Hungary, and the Kurdistan Region of Iraq. The company was founded by Alex Cranberg in 1993 and is headquartered Denver, CO.
Hungarian Horizon Energy Ltd.
Hungarian Horizon Energy Ltd. Oil & Gas ProductionEnergy Minerals Part of Aspect Energy LLC (Colorado), Hungarian Horizon Energy Ltd. is a company that engages in exploring gas. The company is based in Budapest, Hungary. The CEOs are Robert Todd Neugebauer, Alex M. Cranberg. The company was founded by Ibolya Ernyey. | 13 years |
Stephen Rubino | M | 65 |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | - |
Michael Wyzga | M | 69 |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | - |
Karthik Radhakrishnan | M | 53 |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | - |
Walker Monfort | M | - |
Alliance for Choice in Education
| - |
Ann Killary | F | - |
The Board of Regents of The University of Texas System
The Board of Regents of The University of Texas System General GovernmentGovernment Part of The University of Texas at Austin, The Board of Regents of The University of Texas System oversees college activities. The company is based in Austin, TX. | - |
Dana Levy | F | - |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | - |
Harold Levy | M | - |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | - |
Louis Feinberg | M | - |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | - |
Robert Z. Orlowski | M | - |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | 5 years |
Peter Feinberg | M | 63 |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | 4 years |
Rachel Humphrey | M | 62 |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan.
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | 2 years |
Ibolya Ernyey | F | - |
Hungarian Horizon Energy Ltd.
Hungarian Horizon Energy Ltd. Oil & Gas ProductionEnergy Minerals Part of Aspect Energy LLC (Colorado), Hungarian Horizon Energy Ltd. is a company that engages in exploring gas. The company is based in Budapest, Hungary. The CEOs are Robert Todd Neugebauer, Alex M. Cranberg. The company was founded by Ibolya Ernyey. | 26 years |
Alan L. Smith | M | 61 |
QA Global GP LLC
QA Global GP LLC Investment ManagersFinance QA Global GP LLC provides investment advisory services. The private company is based in Houston, TX. The CEO of the company is Alan L. Smith. | - |
Kevin Scott Moore | M | 69 |
Aspect Energy LLC (Colorado)
Aspect Energy LLC (Colorado) Oil & Gas ProductionEnergy Minerals Aspect Energy LLC operates as an exploration and energy investment company. The firm is engaged in oil and gas exploration and development efforts. The company was founded in 1992 and is headquartered in Denver, CO.
Aspect Holdings LLC
Aspect Holdings LLC Financial ConglomeratesFinance Aspect Holdings LLC provides investments in oil and gas exploration companies. It engages in exploration and production activities in a number of countries, including the United States, Hungary, and the Kurdistan Region of Iraq. The company was founded by Alex Cranberg in 1993 and is headquartered Denver, CO. | 32 years |
Elan Ezickson | M | 60 |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | - |
John H. Campbell | M | 66 |
QA Global GP LLC
QA Global GP LLC Investment ManagersFinance QA Global GP LLC provides investment advisory services. The private company is based in Houston, TX. The CEO of the company is Alan L. Smith. | - |
Ronald DePinho | M | 69 |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | 5 years |
Toby R. Neugebauer | M | 53 |
QA Global GP LLC
QA Global GP LLC Investment ManagersFinance QA Global GP LLC provides investment advisory services. The private company is based in Houston, TX. The CEO of the company is Alan L. Smith. | - |
Wil VanLoh | M | 53 |
QA Global GP LLC
QA Global GP LLC Investment ManagersFinance QA Global GP LLC provides investment advisory services. The private company is based in Houston, TX. The CEO of the company is Alan L. Smith. | - |
Donald D. Wolf | M | 80 |
Aspect Energy LLC (Colorado)
Aspect Energy LLC (Colorado) Oil & Gas ProductionEnergy Minerals Aspect Energy LLC operates as an exploration and energy investment company. The firm is engaged in oil and gas exploration and development efforts. The company was founded in 1992 and is headquartered in Denver, CO.
Aspect Holdings LLC
Aspect Holdings LLC Financial ConglomeratesFinance Aspect Holdings LLC provides investments in oil and gas exploration companies. It engages in exploration and production activities in a number of countries, including the United States, Hungary, and the Kurdistan Region of Iraq. The company was founded by Alex Cranberg in 1993 and is headquartered Denver, CO. | - |
Matt Lengel | M | - |
Alliance for Choice in Education
| - |
Natasha Harris | F | - |
Alliance for Choice in Education
| - |
Richard Helfers | M | - |
The Board of Regents of The University of Texas System
The Board of Regents of The University of Texas System General GovernmentGovernment Part of The University of Texas at Austin, The Board of Regents of The University of Texas System oversees college activities. The company is based in Austin, TX. | - |
Fadi Khasawneh | M | - |
The Board of Regents of The University of Texas System
The Board of Regents of The University of Texas System General GovernmentGovernment Part of The University of Texas at Austin, The Board of Regents of The University of Texas System oversees college activities. The company is based in Austin, TX. | - |
Eric Billinger | M | - |
Alliance for Choice in Education
| - |
Elliot Justin | M | - |
Alliance for Choice in Education
| - |
Joe Niebur | M | - |
Alliance for Choice in Education
| - |
Jenni Leach | F | - |
Alliance for Choice in Education
| - |
Jennifer True | F | - |
Alliance for Choice in Education
| - |
Jeremy Shevlin | M | - |
Alliance for Choice in Education
| - |
Chris Halstedt | M | - |
Alliance for Choice in Education
| - |
Rob Peirce | M | - |
Alliance for Choice in Education
| - |
Stuart Atnip | M | - |
Alliance for Choice in Education
| - |
Ralph Stephens | M | - |
Alliance for Choice in Education
| - |
Joe Billion | M | - |
Alliance for Choice in Education
| - |
Evan Burden | M | - |
Alliance for Choice in Education
| - |
Christian Bienvenu | M | - |
Alliance for Choice in Education
| - |
Peter Krahn | M | - |
Alliance for Choice in Education
| - |
Caleb Neumeyer | M | - |
Alliance for Choice in Education
| - |
Ryan Goethals | M | - |
Alliance for Choice in Education
| - |
Mary Whetzal | F | - |
Alliance for Choice in Education
| - |
Carl Piske | M | - |
Alliance for Choice in Education
| - |
Bobbi Grigsby | F | - |
Alliance for Choice in Education
| - |
Brian Hartley | M | - |
Alliance for Choice in Education
| - |
Susan Schmitz | F | - |
Alliance for Choice in Education
| - |
Beth Carr | F | - |
Alliance for Choice in Education
| - |
Sara Montgomery | F | - |
Alliance for Choice in Education
| - |
Gretchen Mclaughlin | F | - |
Alliance for Choice in Education
| - |
Vincenzo Artino | M | - |
Alliance for Choice in Education
| - |
Jenna Stapleton | F | - |
Alliance for Choice in Education
| - |
Mike DeHart | M | - |
Alliance for Choice in Education
| - |
John Francis Cogan | M | 76 |
Stanford University
| 44 years |
Peter Coors | M | 77 |
Alliance for Choice in Education
| - |
R. Sellers | M | 67 |
Alliance for Choice in Education
| - |
James Marshall Piccone | M | 72 |
Alliance for Choice in Education
| - |
Richard H. Lewis | M | 74 |
Alliance for Choice in Education
| - |
Christopher Wright | M | 59 |
Alliance for Choice in Education
| - |
Kevin Ahern | M | 60 |
Alliance for Choice in Education
| - |
Phillip Scott Lowery | M | - |
Alliance for Choice in Education
| - |
Marvin E. McDaniel | M | 64 |
Alliance for Choice in Education
| - |
George P. Caulkins | M | 60 |
Alliance for Choice in Education
| 20 years |
Audrey Robertson | F | 43 |
Alliance for Choice in Education
| - |
Scott Clark | M | - |
Alliance for Choice in Education
| 1 years |
Jon Kinning | M | - |
Alliance for Choice in Education
| - |
Arthur Dupre | M | - |
Alliance for Choice in Education
| - |
Nate Schnabel | M | - |
Alliance for Choice in Education
| - |
Carla Villegas | F | - |
Alliance for Choice in Education
| - |
Janet Hernandez | F | - |
Alliance for Choice in Education
| - |
Karen Perez | F | - |
Alliance for Choice in Education
| - |
Jasmine Luna | F | - |
Alliance for Choice in Education
| - |
Jorge Jaquez | M | - |
Alliance for Choice in Education
| - |
Jennifer Navarro | F | - |
Alliance for Choice in Education
| - |
Alvin Peregrino | M | - |
Alliance for Choice in Education
| - |
Erica Maes | F | - |
Alliance for Choice in Education
| - |
Sharon Maffei | F | - |
Alliance for Choice in Education
| - |
Melissa Corrado-Harrison | F | - |
Alliance for Choice in Education
| - |
Craig Kinard | M | - |
Alliance for Choice in Education
| - |
Chris Murdy | M | - |
Alliance for Choice in Education
| - |
Melanie Schmieding | F | - |
Alliance for Choice in Education
| - |
Norton Rainey | M | - |
Alliance for Choice in Education
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Wurzburg | M | - |
Stanford University
| 8 years |
James W. Cicconi | M | 71 |
The University of Texas at Austin
| 7 years |
McHenry Tichenor | M | 68 |
The University of Texas at Austin
| 6 years |
Chuck Stonecipher | M | - |
Stanford University
| 5 years |
Greg Cox | M | - |
The University of Texas at Austin
| 6 years |
Rena Shpiegel | F | - |
The University of Texas at Austin
| 6 years |
James H. Stokes | M | 66 |
The University of Texas at Austin
| 7 years |
David Lamar Hallman | M | - |
The University of Texas at Austin
| 6 years |
John J. Kopchick | M | - |
The University of Texas at Austin
| 3 years |
Heidi Roizen | F | 66 |
Stanford University
| 7 years |
Richard Langdon | M | 74 |
The University of Texas at Austin
| 6 years |
L. Steven Leshin | M | - |
The University of Texas at Austin
| 3 years |
Kenneth G. Hawari | M | 65 |
The University of Texas at Austin
| 4 years |
Jean-Michel Valette | M | 63 |
Stanford University
| 5 years |
Howard Roy Gleicher | M | - |
Stanford University
| 5 years |
Kurt Richard Jaggers | M | 66 |
Stanford University
| 4 years |
Gerard Arpey | M | 65 |
The University of Texas at Austin
| 6 years |
Jane Woodward | F | 64 |
Stanford University
| 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Hungary | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alex M. Cranberg
- Personal Network